Clinical Trials Browser

Phase 1/2 × INDUSTRY × irinotecan sucrosofate × Clear all

NCT02785068 2017-01-11

Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Neoplasms, Colorectal Neoplasms